Anavex Life Sciences Corp (AVXL)

[Investor2014]

Explore the development of a policy framework under which an accelerated approval approach could be used to support marketing of a drug that demonstrates a survival benefit early in clinical development. The goal is to expedite availability of a therapy while the magnitude of the benefit it provides is being confirmed

A daring and probably silly thought - could it be that based upon the many confirmations from independent research and clinical longitudinal results regarding safety and indicative efficacy correlated across multiple measures, that the wait is a calculated one potentially leading to accelerated approval.

An interesting contradiction in terms, which if it comes to pass will shake the market by its foundations.